Skip to main content
TipRanks
Go Ultimate75% OFF

Senti Biosciences (SNTI) Drug Pipeline

270 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Senti-202Aml/Mds, Cd33 Expressing Hematological Malignancies, Flt3 Expressing Hematological MalignanciesPhase IRecruitingSENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDSMar 13, 2024―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Senti Biosciences, Inc. (SNTI) have in its pipeline
Senti Biosciences SNTI is currently developing the following drugs: Senti-202. These drug candidates are in various stages of clinical development as the company works toward FDA approval.